STERLING NICHOLSON: Open Payments
NPI 1861018897 · DANBURY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,478 in 92 payments from 15 companies in 2025. Trend: 2023 $2,316 · 2024 $1,728 · 2025 $1,478
Food & beverage: $1,478
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $407 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $234 |
| PFIZER INC. | 13 | $196 |
| AstraZeneca Pharmaceuticals LP | 9 | $182 |
| Lilly USA, LLC | 6 | $112 |
| Novo Nordisk Inc | 5 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $62 |
| Amgen Inc. | 3 | $49 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
Products named: JARDIANCE, QULIPTA, UBRELVY, ELIQUIS, MOUNJARO, CAPLYTA, AIRSUPRA, NURTEC ODT.
Industry payments across NC — which companies pay providers there.
